Delivery Order SPE2DE24D0013-SPE2D625F3BVW

The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection, which aligns with Cepheid's core business providing GeneXpert diagnostic systems and associated test kits for infectious disease detection.

This award is likely executed under one of Cepheid's two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs' Veterans Integrated Service Networks—specifically the $32.8 million IDV with VA VISN 6 or the $2.5 million IDV with VA VISN 21, both of which support procurement of molecular diagnostic testing system reagents, assays, and PCR testing services for conditions including COVID-19, influenza, RSV, and tuberculosis. Cepheid's established market position in federal molecular diagnostics, combined with its track record serving the VA, Defense Logistics Agency, and Defense Health Agency, demonstrates the company's capability to deliver specialized diagnostic solutions supporting federal healthcare operations and military readiness initiatives.